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ABSTRACT 
Objective: To investigated the growth-inhibiting and apoptosis mediating effect of Plectranthus amboinicus (Lour.) Spreng ethyl acetate extract (PAE) in 
combination therapy with doxorubicin against T47D cell lines, to analyzed the expression of cyclin D1 and COX-2 (cyclooxigenase-2) proteins.  
Methods: The assays were performed in the study were cytotoxicity assay, cell cycle assay, apoptosis induction, and immunocytochemistry of T47D 
cells. The cytotoxicity effects were determined by using MTT [3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyl tetrazolium bromide] assay. The effect on 
modulation of cell cycle and apoptosis was observed by flow cytometry assay in both single dose of PAE and its combination with doxorubicin. The 
expression of cyclin D1 and COX-2 proteins on T47D cell lines was identified by using immunocytochemistry.  
Results: The result showed that the PAE 8 µg/ml had the synergistic effect with doxorubicin against T47D cells based on Combination Index 
analysis. The PAE induced apoptosis and cell accumulation at G1 phase. The combination of PAE 8 µg/ml with doxorubicin 1 µg/ml caused 
apoptosis induction same with its single treatment, but there was increasing in cell accumulation at G1 phase. Expression of cyclin D1 indicated that 
both single application and combination of PAE with doxorubicin could arrest the cell cycle of T47D cells. The expression of COX-2 showed that the 
combination could inhibit the metastasis of T47D breast cancer cells.  
Conclusion: Based on the result that PAE could be a potential co-chemoterapeutic agent with doxorubicin on breast cancer cells. 
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INTRODUCTION 
Doxorubicin is one of chemotherapeutic agents which is widely used for 
breast cancers and it causes some problems such as drug resistance and 
toxic effects on normal tissue [1]. Cancer cells which are resistance have 
ability to avoid apoptosis and may cause cell growth was not restrained 
[2]. Combination of chemoterapeutics and chemopreventive agent with 
target cell cycle modulation and apoptosis was conducted to increase an 
efficacy of chemoterapeutics [3]. 
Plectranthus amboinicus, (Lour.) Spreng is used for lactagogue in 
Bataknese, North Sumatera. There are some informations about its 
effects such as antiinflammatory, anti clastogenic, nephroprotective 
and hepatoprotective. The previous studies had showed that the n-
hexane, ethyl acetate and ethanol extracts of Plectranthus 
amboinicus, (Lour.) Spreng. had antioxidant activity. The n-hexane 
and ethyl acetate extracts exhibited strong cytotoxic effect on T47D 
breast cancer cells with IC50
This research was conducted to investigated the growth-inhibiting 
and apoptosis mediating effect of Plectranthus amboinicus, (Lour.) 
Spreng ethyl acetate extract (PAE) in combination therapy with 
doxorubicin against T47D cell lines. Further, suppression of cyclin 
D1 and BCl-2 on T47D breast cancer cells was analyzed.  
 value of 44.716 µg/ml and 37.61 µg/ml, 
respectively[4]. Antioxidant activity is usually correlated with 
cancer prevention. Thus, the extract has potential effect as a 
chemoprevention. A combination of chemotherapeutic agent and 
chemopreventive agent decrease side effect and become an effective 
strategy to cure cancer[2].  
MATERIALS AND METHODS 
Plant material 
Fresh leaves of Plectranthus amboinicus, (Lour.) Spreng. was 
collected from Pematang Siantar, Simalungun regency, Sumatera 
Utara province, Indonesia. Plectranthus amboinicus, (Lour.) Spreng. 
was identified in Research Centre for Biology, Indonesian Institute of 
Science, Bogor, and the voucher specimen was deposited in 
herbarium. Doxorubicin (Ebewe). DMSO (Sigma), [3-(4,5-
dimethylthiazole-2-yl)-2,5-diphenyl tetrazolium bromide] (MTT) 
(Sigma), H2O2
Preparation of ethylacetate extract (PAE) 
 (Lab Vision Plus), chromogen 3,3-diaminobenzidin 
(DAB) (Novo Castra). 
The air-dried and powdered leaves of Plectranthus 
amboinicus, (Lour.) Spreng. (1 kg) were repeatedly extracted by cold 
maceration with n-hexane (3x3 d, 7.5 L). The powder was dried in 
the air and extracted with ethyl acetate (3x3 d, 7.5 L) at room 
temperature on a shake. The filtrate was collected, and then 
evaporated under reduced pressure by rotary evaporator (Heidolph 
VV-200) to obtain a viscous extract and the concentrated extract was 
dried by freeze-dryer (Edwards). 
Cytotoxicity assay 
Cytotoxicity was determined by the MTT assay 
Briefly, T47D cells were plated at 104 cells/well in a 96-well plate. 
After incubation for 24 h at 37o
Flowcytometry assay 
C, cells were treated by Plectranthus 
amboinicus etylacetate extract (PAE) with different concentration 
and incubated for 24 h. MTT solution was added to each well and 
further incubated for 4h at 37 °C, optical density was read with an 
ELISA reader at 595 nm[5]. 
Cell cycle inhibition assay 
T47D cells (1x106 cells/well) were seeded into 6-well plate and 
incubated for 24 h. After that, the cells were treated with PAE, 
doxorubicin and their combination, and then incubated for 24 h. 
Both floating and adherent cells were collected in the conical tube 
using tripsin 0.025%. The cells were washed thrice with cold PBS 
and centrifuged 2500 rpm for 5 min. The supernatant was 
separated, while the sediment was collected and fixed in cold 70% 
ethanol in PBS at-20 oC for 2 h. The cells were washed thrice with 
cold PBS and re suspended then centrifuged 3000 rpm for 3 min and 
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PI kit (containing PI 40 µg/ml and RNAse 100 µg/ml) added to 
sediment and re suspended and incubated at 37oC for 30 min. The 
samples were analysed using FACScanflowcytometer. Based on DNA 
content, percentage of cells in each of stage in cell cycle (G1, S and 
G2/M) were calculated using ModFit Lt. 3.0. s [6, 7]. 
Apoptosis assay 
T47D cells (5x105 cells/well) were seeded into 6-well plate and 
incubated for 24 h. After that, the cells were treated with PAE, 
doxorubicin and their combination, and then incubated for 24 h. Both 
floating and adherent cells were collected in the conical tube using 
trypsin 0.025%. The cells were washed thrice with cold PBS and 
centrifuged 2500 rpm for 5 min. The supernatant was separated, while 
the sediment was collected and fixed in cold 70% ethanol in PBS at-
20oC for 2 h. The cells were washed thrice with cold PBS and 
centrifuged in 2500 rpm for 5 min. The supernatant was separated, 
while the sediment was collected and fixed in cold 70% ethanol in PBS 
at-20oC for 2 h. The cells were washed thrice with cold PBS and 
suspended then centrifuged 3000 rpm for 3 min and Annexin V kit 
added to sediment and suspended and incubated at 37o
T47D cells (5x10
C for 30 min. 
The samples were analyzed using FACScan flow cytometer [8]. 
Immunocytochemistry  
4 cells/well) were seeded on cover slips in 24-well 
plate and incubated for 24 h. After that, the cells were treated with 
PAE, doxorubicin and their combination, and then incubated for 24 
h. After incubation, the cells were washed with PBS and then fixed 
with cold methanol at 4o
RESULTS 
C for 10 min. After that, the cells were 
washed with PBS and blocked in hydrogen peroxide blocking 
solution for 10 min at room temperature, incubated using primary 
antibody Bcl-2 and cyclin D1 for 1 h, then washed thrice with PBS, 
then incubated with secondary antibody for 10 min. The cells were 
washed with PBS, then incubated in 3,3-diaminobenzidin (DAB) 
solution for 10 min, and washed with aquadest. Afterward, the cells 
were counter stained with Mayer-Haematoxylin for 5 min, and the 
cover slips were taken and washed with aquadest, and then 
immersed with xylol and ethanol 70%. Protein expression observed 
by light microscope (Nikon YS100). Cells that express a particular 
protein will provide the brown colour, while the cells that does not 
give a specific protein will provide blue colour[2]. 
Synergistic effect of combination between PAE and doxorubicin 
could be occured via cell cycle modulation (table 1 and fig. 1). Cell 
cycle analysis of T47D breast cancer cell lines showed that single 
treatment of doxorubicin induced G0-G1 arrest. Single treatment of 
PAE induced G0-G1 arrest, while in combination with doxorubicin 
induced cell accumulation in G0-G1 phase, as well. However, the 
combination doxorubicin-PAE remained lower cell accumulation on 
G0-G1
Evaluation of apoptotic induction was performed by using 
flowcytometry assay with Annexin V. As shown in fig. 2, the cells in 
the upper and lower right quadrants represent late apoptotic/ 
necrotic and early apoptotic cells, respectively. The percentage of 
PAE, their combination, and doxorubicin in early apoptotic was 
6.56%; 15.48%; and 7.04%, respectively. Meanwhile, in late 
apoptotic/early necrotic the percentage was 15.82%; 1.65%; and 
22.03%, and then in late necrotic were 48.20%; 3.10%; and 67.77%, 
respectively. The combination of PAE-doxorubicin exhibited higher 
in nearly apoptotic compared to PAE and doxorubicin single 
treatments.  
 phase compared to PAE and doxorubicin single treatments. 
These facts indicated that the combination needs to be optimized. 
The observation of expression of cell cycle regulator protein Cyclin 
D1 and angiogenic factor protein COX-2 was conducted in T47D cells 
by using PAE and doxorubicin, both a single application or in 
combination of them. In this study, the effects of PAE, doxorubicin 
and their combination on cyclin D1 and COX-2 were evaluated by 
using immunocytochemistry. The expression of cyclin D1and COX-2 
proteins is positive characterized by brown stained nuclei in the 
cells (fig. 3 and fig. 4). High intensity of brown colour was shown on 
untreated cells (negative control) for cyclin D1 and COX-2 proteins. 
A single treatment of PAE decreased the cyclin D1 and COX-2 
proteins expression. Single treatment of doxorubicin did not 
decrease cyclin D1 and COX-2 expression. However, the combination 
of PAE and doxorubicin was decreased these proteins expressions. 
 
Table 1: MCF7 cells distribution after treatment of PAE, doxorubicin, and their combination for 24 h 
Treatments Concentration  Cell phase (%) 
G0-G S 1 G2–M 
control - 33.12 26.66 15.82 
PAE  8 µg/ml 36.99 25.90 10.16 
Doxo-PAE 1 µg/ml-8µg/ml  34.26 27.82 12.05 
Doxorubicin 1 µg/ml 58.77 19.13 3.06 
 
 
a. control T47D 
 
b. PAE 8 µg/ml 
 
c. doxo1 µg/ml–PAE 8 µg/ml  c. doxorubicin 1 µg/ml on T47D 
Fig. 1: Cell cycle analysis using flowcytometry. T47D cells were treated by doxorubicin, PAE, and their combination for 24 h and stained by 
using Propidium Iodide. (a) control cells; (b) PAE 8 µg/ml; (c) Doxo 1 µg/ml–PAE 8 µg/ml 
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Fig. 2:Apoptotic analysis of PAE, doxorubicin and their combination on T47D cell lines. (a) cells control; (b) combination of PAE 8 µg/ml 






Fig. 3: Expression of cyclin D1 on T47D cells using immunocytochemistry. (a) control cells; (b) PAE 8 µg/ml; (c) doxorubicin 1 µg/ml; (d) 
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Fig. 4. Expression of COX-2 on T47D cells using immunocytochemistry. (a) control cells; (b) PAE 8 µg/ml; (c) doxorubicin 1 µg/ml; (d) 
combination of PAE 8 µg/ml and doxorubicin 1 µg/ml. (  positive expression;  negative expression) 
 
DISCUSSION 
The Plectranthus amboinicus, (Lour.) Spreng. leaves are used as 
lactagogue by native people in North Sumatera, Indonesia. One of its 
compounds is ursolic acid, which is known have chemotherapeutic 
effect [9, 10]. The result of cytotoxic assay estimated that this plant 
has the potential effect as anticancer[5]. Doxorubicin is one of 
chemotherapeutic agents which is less toxic to T47D cell lines 
because of the cell resistant by p53 mutation[11]. 
This study has shown that the PAE could induce the cell accumulation 
on G0-G1 phase but its combination with doxorubicin did not show cell 
accumulation. While the combination of PAE and doxorubicin showed 
increasing early apoptotic induction compared to late apoptotic/early 
necrotic and late necrotic. The cell growth retardation is possible 
through the cell cycle regulatory mechanisms. Both the single 
treatment of PAE and its combination with doxorubicin induced cell 
accumulation in G1 phase, it is probably because of the ursolic acid 
effect. In vitro studies have shown that this compound in other plants 
reportedly inhibit the growth of numerous tumor cell lines including 
colon, breast, liver, prostate, and leukemia and inhibit the expression 
and activity of cyclo oxigenases [10, 11]. But the mechanisms need to 
be explored further.  
The expression of cyclin D1 of either single treatment or their 
combination strengthen the information about the effect of them on 
cell cycle accumulation especially in inhibition of cell cycle on G0-G1 
phase. Cyclin D1 play an important role in G0-G1 phase. The complex 
of cyclin D1 with CDK-4 or CDK-6 controlled G1 to S phase transition. 
Despite combination of PAE-doxorubicin could inhibit the cell cycle 
by decreasing level of cyclin D1
Based on the results, we concluded that the combination of ethyl 
acetate extracts of Plectranthus amboinicus, (Lour.) Spreng. with 
doxorubicin could increase the cell cycle arrest, inducing apoptotic, 
and decrease cyclin D
, it resulted inhibition of pRb 
phosphorylation. So, E2F cannot a part from pRb, and cells can not 
transcribes genes which is needed in cell cycle process or cell 
proliferation[7, 8].  
Both single treatment and combination of PAE-doxorubicin did not 
express of COX-2 protein. It may be caused by ursolic acid effect 
which is known decrease the expression of matrix metallo-
proteinase-9 (MMP-9). Matrix metalloproteinase activities are 
involved in the remodelling of the extracellular matrix, part of the 
tumor micro-environment, and are thus linked to tumor invasion 
and increased risk of metastasis [11]. 
However, the molecular mechanisms of cell cycle modulation, 
apoptosis induction and potential anti angiogenic of this 
combination need to be explored more detail.  
CONCLUSION 
1
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 and COX-2 expressions. The extract has 
potential effect as co-chemoterapeutic agent for doxorubicin in 
breast cancer therapy. 
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